These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7008743)

  • 1. Factors influencing outcome of kidney allografts from pretreated cadaveric donors.
    Sterioff S; Zincke H; Waltzer WC; Moore SB; Frohnert PP; Offord KP
    Arch Surg; 1981 Jan; 116(1):73-7. PubMed ID: 7008743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized prospective study of cadaver donor pretreatment in renal transplantation.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):287-9. PubMed ID: 351886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP; Baron D; Rouxel A; Guenel J
    Nephron; 1979; 24(4):193-7. PubMed ID: 386157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor pretreatment in cadaver renal transplantation.
    Zincke H; Woods JE
    Surg Gynecol Obstet; 1977 Aug; 145(2):183-8. PubMed ID: 327596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H; Woods JE; Khan AU; Holley KE; Leary FJ
    Transplantation; 1978 Oct; 26(4):207-11. PubMed ID: 360522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of 100 primary cadaver kidney transplants.
    Barry JM; Craig DH; Fischer SM; Fuchs EF; Lawson RK; Bennett WM
    J Urol; 1980 Dec; 124(6):783-6. PubMed ID: 7003171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of recipient blood transfusion and donor pretreatment with cyclophosphamide and methylprednisolone.
    Corry RJ; West JC
    Transplant Proc; 1981 Mar; 13(1 Pt 1):161-3. PubMed ID: 7022814
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of blood transfusions to improve cadaveric renal allograft survival.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):344-5. PubMed ID: 351896
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor pretreatment as an adjunct to cadaveric renal transplantation--update 1979.
    Guttmann RD; Morehouse DD; Meakins JL; Milne CA; Knaack J
    Transplant Proc; 1980 Jun; 12(2):341-7. PubMed ID: 6994304
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary cadaver kidney transplant survival after donor pretreatment with cyclophosphamide and methylprednisolone.
    Barry JM; Bennett WM
    Transplantation; 1978 Sep; 26(3):202-3. PubMed ID: 360520
    [No Abstract]   [Full Text] [Related]  

  • 16. Donor pretreatment on perfused cadaver kidneys: experimental observations.
    Sy G; Taiyebb S; Toledo-Pereyra LH
    Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513
    [No Abstract]   [Full Text] [Related]  

  • 17. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328
    [No Abstract]   [Full Text] [Related]  

  • 18. Pretreatment of cadaver donors with methylprednisolone in human renal allografts.
    Chatterjee SN; Terasaki PI; Fine S; Schulman B; Smith R; Fine RN
    Surg Gynecol Obstet; 1977 Nov; 145(5):729-32. PubMed ID: 333644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.